 |
|
|
| | Monday, April 21, 2014 |
|
|
|
| 1:00 p.m. |
|
Thesis Presentations
Causes and Consequences of Genetic Robustness and Fragility in HIV-1 Proteins
Suzannah Rihn, graduate fellow, The Rockefeller University
|
| 5:00 p.m. |
|
Other Tri-Institutional Events
Diversity and Design: New Chemical Probes for Biology and Medicine
Sloan Kettering Institute Talks
Derek Tan, Ph.D., member, Molecular Pharmacology & Chemistry Program, Sloan Kettering Institute
|
|
| | Wednesday, April 23, 2014 |
|
|
|
| 4:30 p.m. |
|
MSKCC President's Research Seminar
Can Aneuploidy be Targeted by Anti-cancer Therapeutics?
Tak Mak, Ph.D., professor, departments of medical biophysics and immunology, University of Toronto
|
|
| | Thursday, April 24, 2014 |
|
|
|
| 11:00 a.m. |
|
Other Tri-Institutional Events
Chaperones for RuBisCO, the Most Abundant Protein
Manajit Hayer-Hartl, Ph.D., research group leader, Max Planck Institute of Biochemistry
|
|
| | Friday, April 25, 2014 |
|
|
|
| 3:45 p.m. |
|
Friday Lecture Series
Reinventing Human Immunology
Mark M. Davis, Ph.D., The Burt and Marion Avery Family Professor of Immunology; director, Stanford Institute for Immunity, Transplantation and Infection; member, Bio-X, Child Health Research Institute and Stanford Cancer Institute, Stanford University
|
